Clinical trial C101
Open, non-controlled, multicenter, first-in-human study for the evaluation of the safety, pharmacokinetics and preliminary antitumor activity of GM102 in patients with advanced pretreated gynecological cancer
| Cancers | |
|---|---|
| Organ | Multiple |
| Trial status | Trial closed |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1 |
| Academic trial | Non |
| Sponsor | Gamamabs Pharma |
| EudraCT Identifier | 2015-004252-22 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02978755 |
| Inclusion criteria | Any line RECIST 1.1 |
| Last update |